HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.

Abstract
Since HIV requires CD4 and a co-receptor, most commonly C-C chemokine receptor 5 (CCR5), for cellular entry, targeting CCR5 expression is an attractive approach for therapy of HIV infection. Treatment of CD4(+) T cells with zinc-finger protein nucleases (ZFNs) specifically disrupting chemokine receptor CCR5 coding sequences induces resistance to HIV infection in vitro and in vivo. A chimeric Ad5/F35 adenoviral vector encoding CCR5-ZFNs permitted efficient delivery and transient expression following anti-CD3/anti-CD28 costimulation of T lymphocytes. We present data showing CD3/CD28 costimulation substantially improved transduction efficiency over reported methods for Ad5/F35 transduction of T lymphocytes. Modifications to the laboratory scale process, incorporating clinically compatible reagents and methods, resulted in a robust ex vivo manufacturing process capable of generating >10(10) CCR5 gene-edited CD4+ T cells from healthy and HIV+ donors. CD4+ T-cell phenotype, cytokine production, and repertoire were comparable between ZFN-modified and control cells. Following consultation with regulatory authorities, we conducted in vivo toxicity studies that showed no detectable ZFN-specific toxicity or T-cell transformation. Based on these findings, we initiated a clinical trial testing the safety and feasibility of CCR5 gene-edited CD4+ T-cell transfer in study subjects with HIV-1 infection.
AuthorsDawn A Maier, Andrea L Brennan, Shuguang Jiang, Gwendolyn K Binder-Scholl, Gary Lee, Gabriela Plesa, Zhaohui Zheng, Julio Cotte, Carmine Carpenito, Travis Wood, S Kaye Spratt, Dale Ando, Philip Gregory, Michael C Holmes, Elena E Perez, James L Riley, Richard G Carroll, Carl H June, Bruce L Levine
JournalHuman gene therapy (Hum Gene Ther) Vol. 24 Issue 3 Pg. 245-58 (Mar 2013) ISSN: 1557-7422 [Electronic] United States
PMID23360514 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • CD28 Antigens
  • CD3 Complex
  • Receptors, CCR5
  • DNA Restriction Enzymes
Topics
  • Adenoviruses, Human (genetics)
  • Adoptive Transfer
  • Animals
  • CD28 Antigens (immunology)
  • CD3 Complex (immunology)
  • DNA Restriction Enzymes (genetics, metabolism)
  • Female
  • Genetic Vectors (administration & dosage, adverse effects, genetics, standards)
  • HIV Infections (genetics, immunology, therapy)
  • Humans
  • Lymphocyte Activation (immunology)
  • Male
  • Mice
  • Phenotype
  • Receptors, CCR5 (genetics, immunology)
  • T-Lymphocytes (immunology, metabolism)
  • Transduction, Genetic (methods, standards)
  • Transplantation, Heterologous
  • Zinc Fingers (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: